Riskpilot← Back to searchSign inGet full accessCoronar Consult AB
ABActiveOrg 5590563556Valentin Sabbats Gata 4 2trMedical specialists activities · NACE 8622Est. 20160 employees
Revenue 2025
SEK 0
EBITDA margin
—
-147% vs 2024
Equity ratio
88.7%
Financial strength
Net profit 2025
SEK -37K
-131% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -100K | -147% |
| Net profit | SEK -37K | -131% |
| Total assets | SEK 115K | -72% |
| Equity | SEK 102K | -65% |
| Employees | 0 | — |
Legal name
Coronar Consult AB
Org number
5590563556
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 mars 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom medicin, livsvetenskap (life sciences) och medicinteknik.
Address
Valentin Sabbats Gata 4 2tr
Email
istvan.herzfeld@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 215 | 181 | 154 | 355 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −73 | 9 | 82 | 211 | −100 |
| Depreciation & amort. | −5 | −0 | −0 | −0 | −0 |
| EBIT | −78 | 9 | 82 | 211 | −100 |
| Net financials | — | — | — | 1 | — |
| Profit before tax | −78 | 9 | 76 | 156 | −37 |
| Tax | −0 | −0 | −5 | −35 | −0 |
| Net profit | −78 | 9 | 71 | 121 | −37 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 134 | 117 | 213 | 418 | 115 |
| Equity | 89 | 97 | 168 | 289 | 102 |
| Long-term debt | 27 | 3 | 5 | 8 | 13 |
| Short-term debt | 18 | 16 | 32 | 58 | 0 |
| Total debt | 45 | 19 | 37 | 66 | 13 |
EBITDA margin
-10000000.0%
This company
15.8%
Market median
-63291239% vs market
20212025
Equity ratio
88.7%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
-36.3%
This company
18.4%
Market median
-297% vs market
20212025
Net profit margin
-3700000.0%
This company
8.1%
Market median
-45679112% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Coronar Consult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Istvan Herzfeld | Board of Directors | 0 companies |
| Jessica Sandra Schubert | Board of Directors | 0 companies |
| Anna Clara H Josephine Herzfeld | Deputy Board Member | 0 companies |